Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- XER-001Phase 21 trial
Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma
- XJN010Phase 21 trial
Guangzhou Novaken Pharm Co., Ltd. · Parkinson Disease
- XmAb942Phase 21 trial
Xencor, Inc. · Ulcerative Colitis (UC)
- XNW29016PARGiPhase 21 trial
Evopoint Biosciences Inc. · Tumor, Solid
- XNW34017Phase 21 trial
Evopoint Biosciences Inc. · Advanced Solid Tumors
- XP-102Phase 21 trial
Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma
- XPro1595INB03, XProPhase 21 trial
Inmune Bio, Inc. · Alzheimer Disease, Dementia, Brain Diseases
- XS-03Phase 21 trial
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Colorectal Cancer, Metastatic Colorectal Cancer With RAS Mutation
- XTX202Phase 21 trial
Xilio Development, Inc. · Advanced Solid Tumor
- XTX301Phase 21 trial
Xilio Development, Inc. · Advanced Solid Tumor
- XTX501Phase 21 trial
Xilio Development, Inc. · Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor
- XY03-EAper dosePhase 21 trial
Shijiazhuang Yiling Pharmaceutical Co. Ltd · Stroke, Ischemic
- XYA02Phase 21 trial
XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer
- XZP-5955Phase 21 trial
Xuanzhu Biopharmaceutical Co., Ltd. · Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Y101DPhase 21 trial
Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma
- YA-101Phase 21 trial
Dasher Neuroscience Inc. · Multiple System Atrophy
- YCT-529Phase 21 trial
YourChoice Therapeutics, Inc. · Male Contraception
- YD0743Phase 21 trial
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Sepsis
- YH32364Phase 21 trial
Yuhan Corporation · EGFR Overexpression, Locally Advanced Solid Tumor, Metastatic Solid Tumor
- YH32367Phase 21 trial
Yuhan Corporation · HER2-Positive Solid Tumor
- YH42946Phase 21 trial
Yuhan Corporation · NSCLC (Non-small Cell Lung Cancer), Solid Tumor
- YKST02Phase 21 trial
Excyte Biopharma Ltd · Relapsed or Refractory Multiple Myeloma (RRMM)
- YKYY013Phase 21 trial
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. · HBV (Hepatitis B Virus)
- YL-13027Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
- YMI024Phase 21 trial
Novartis · Coronary Artery Disease
- YR001Phase 21 trial
Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Atopic Dermatitis
- YY003Phase 21 trial
Chongqing Claruvis Pharmaceutical Co., Ltd. · Moderate to Severe Glabellar Lines
- YZJ-4729Phase 21 trial
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Pain
- ZED1227Phase 21 trial
Dr. Falk Pharma GmbH · Celiac Disease
- zetomipzomibKZR-616, zetomipzomib in open-label extensionPhase 21 trial
Kezar Life Sciences, Inc. · Autoimmune Hepatitis
- zevor-celCAR-BCMA T CellPhase 21 trial
CARsgen Therapeutics Co., Ltd. · Multiple Myeloma
- ZL-85FAPhase 21 trial
Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor
- ZSP1601Phase 21 trial
Guangdong Raynovent Biotech Co., Ltd · Nonalcoholic Steatohepatitis (NASH)
- ZT-01Phase 21 trial
Zucara Therapeutics Inc. · Type 1 Diabetes Mellitus With Hypoglycemia
- ZT006Phase 21 trial
Beijing QL Biopharmaceutical Co.,Ltd · Overweight , Obesity
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.